Programmable infusion pumps and catheters market

Programmable Infusion Pumps and Catheters Market, by Product Type (Volumetric Pumps, Syringe Pumps, Enteral Pumps, Insulin Pumps, Implantable Pumps, Patient Controlled Analgesia Pumps, and Pump Accessories), by Modality (Portable and Stationary), by Application (Oncology, Pediatrics/Neonatology, Pain, Gastroenterology, Hematology, and Diabetes), by Channel Type (Single Channel and Multi-Channel), by End User (Hospitals, Ambulatory Clinics, Homecare, Clinics, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018-2026

  • Apr 2019
  • CMI2565
  • 181 Pages
  • Excel & Pdf
  • Medical Devices

Programmable infusion pumps and catheters are devices used for delivering fluids to the patient’s body in a controlled manner. The devices include safety features such as user alerts which are activated when there is a risk of adverse drug interaction, or when the pump’s parameters are set outside its specified safety limits. Infusion pumps are used for different purposes such as delivering nutrients or medications like antibiotics, chemotherapeutic drugs, analgesics, hormones such as insulin, and so on. These are generally designed for stationary use, that is along patient’s bedside in an ICU setting, however few such as the ambulatory infusion pumps, are portable. Infusion pumps are designed for specific purposes. For instance, the enteral pump is designed to deliver medication to patient’s digestive tract through tube feeding.

Increasing launch of novel infusion pumps is expected to boost the global programmable infusion pumps and catheters market growth over the forecast period

Frequent approvals of novel infusion pumps and their launches in developed economies are expected to significantly drive the global programmable infusion pumps and catheters market growth over the forecast period. For instance, in April 2018, Smiths Group plc. launched its new product, CADD-Solis wireless infusion pump, for safe delivery of analgesics. These infusion pumps are portable and have wireless software and drug library updation facility without the need to find, plug in and update the pump personally.

In April 2013, Flowonix Medical Inc., a medical device company involved in the manufacture of implantable drug delivery systems, launched the Prometra programmable intrathecal pump in the U.S. The pump is implantable and effective in delivering Infumorp (preservative free morphine) in patients undergoing treatment for chronic pain as it directly delivers the medication in the intrathecal space around the spinal cord. The Prometra pump uses a dual-gated valve drug delivery mechanism for accurate dosing.

The global programmable infusion pumps and catheters market was valued at US$ 8,365.3 million in 2017, and is expected to witness a robust CAGR of 5.8% over the forecast period (2018–2026).

Figure No.1: Global Programmable Infusion Pumps and Catheters Market Share, By Region (%), 2018 - 2026        

                                                                                                                                                                                                

Source: Coherent Market Insights Analysis (2017)

Company strategies such as acquiring funding for research and product launches, are expected to have a positive impact on global programmable infusion pumps and catheters market growth.

Key players are involved in research and development of new products, which is expected to aid in growth of the market. For instance, in March 2017, Ivenix, Inc., a medical technology company involved in development of next generation infusion systems, raised US$ 50 million. Funds were raised via equity financing led by new undisclosed investors and by participation of existing investors, WuXi Healthcare Ventures and F-Prime Capital Partners, which will be used for pursuing the FDA clearance and commercial launch of products.

Novel programmable infusion pumps have been granted approval by regulatory agencies such as the U.S. Food and Drug Administration (FDA), European Commission (EC), Therapeutic Goods Administration (TGA), and others. For instance, in August 2018, Baxter International Inc. received CE approval for its Evo IQ Infusion System, a programmable volumetric infusion pump, and marketing approval from the Therapeutic Goods Administration (TGA) in Australia. The Evo IQ Infusion System consists of a software for dose error reduction and an advanced drug library to promote patient safety. Such product launches are expected to boost the global programmable infusion pumps and catheters market growth during the forecast period.

Figure No.2: Global Programmable Infusion Pumps and Catheters Market Size (US$ Mn) Analysis and Forecast and Y-o-Y Growth (%)

                   

However, high costs of programmable infusion pumps and catheters is a major concern (in regions with underdeveloped reimbursement facilities) in the healthcare system, and is expected to restrain the global programmable infusion pumps and catheters market growth over the forecast period.

Furthermore, efficient technicians are needed for monitoring of infusion parameters available in the programmable device. These factors are expected to restrain the global programmable infusion pumps and catheters market growth over the forecast period.

Some of the major players operating in the global programmable infusion pumps and catheters market include, ICU Medical, Inc., Smiths Group plc., Baxter International Inc., Fresenius Se & Co. KGaA, Johnson & Johnson, Medtronic plc., Becton, Dickinson and Company, Terumo Corporation, B. Braun Melsungen AG, and Moog Inc.

Table of Contents

  1. Research Objective and assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Modality
      • Market Snippet, By Application
      • Market Snippet, By Channel Type
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Impact Analysis
    • Technological Evolution
    • PEST Analysis
    • Pipeline Analysis
    • Porter’s Analysis
  4. Global Programmable Infusion Pumps and Catheters Market, By Product Type, 2018–2026 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2017 and 2026 (%)
      • Y-o-Y Growth Analysis, 2018–2026
      • Segment Trends
    • Volumetric Pumps
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2026, (US$ Mn)
    • Syringe Pumps
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2026, (US$ Mn)
    • Enteral Pumps
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2026, (US$ Mn)
    • Insulin Pumps
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2026, (US$ Mn)
    • Implantable Pumps
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2026, (US$ Mn)
    • Patient Controlled Analgesia Pumps
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2026, (US$ Mn)
    • Pump Accessories
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2026, (US$ Mn)
  5. Global Programmable Infusion Pumps and Catheters Market, By Modality, 2018–2026 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2017 and 2026 (%)
      • Y-o-Y Growth Analysis, 2018–2026
      • Segment Trends
    • Portable
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2026, (US$ Mn)
    • Stationary
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2026, (US$ Mn)
  6. Global Programmable Infusion Pumps and Catheters Market, By Application, 2018–2026 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2017 and 2026 (%)
      • Y-o-Y Growth Analysis, 2018–2026
      • Segment Trends
    • Oncology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2026, (US$ Mn)
    • Pediatrics/Neonatology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2026, (US$ Mn)
    • Pain
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2026, (US$ Mn)
    • Gastroenterology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2026, (US$ Mn)
    • Hematology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2026, (US$ Mn)
    • Diabetes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2026, (US$ Mn)
  7. Global Programmable Infusion Pumps and Catheters Market, By Channel Type, 2018–2026 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2017 and 2026 (%)
      • Y-o-Y Growth Analysis, 2018–2026
      • Segment Trends
    • Single Channel
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2026, (US$ Mn)
    • Multi-channel
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2026, (US$ Mn)
  8. Global Programmable Infusion Pumps and Catheters Market, By End User, 2018–2026 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2017 and 2026 (%)
      • Y-o-Y Growth Analysis, 2018–2026
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2026, (US$ Mn)
    • Ambulatory Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2026, (US$ Mn)
    • Homecare
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2026, (US$ Mn)
    • Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2026, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018–2026, (US$ Mn)
  9. Global Programmable Infusion Pumps and Catheters Market, By Regions, 2018–2026 (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2017 and 2026 (%)
      • Y-o-Y Growth Analysis, For Regions, 2018–2026
    • North America
      • Market Size and Forecast, By Product Type, 2018–2026 (US$ Mn)
      • Market Size and Forecast, By Modality, 2018–2026 (US$ Mn)
      • Market Size and Forecast, By Application, 2018–2026 (US$ Mn)
      • Market Size and Forecast, By Channel Type, 2018–2026 (US$ Mn)
      • Market Size and Forecast, By End User, 2018–2026 (US$ Mn)
      • Market Size and Forecast, By Country, 2018–2026 (US$ Mn)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Product Type, 2018–2026 (US$ Mn)
      • Market Size and Forecast, By Modality, 2018–2026 (US$ Mn)
      • Market Size and Forecast, By Application, 2018–2026 (US$ Mn)
      • Market Size and Forecast, By Channel Type, 2018–2026 (US$ Mn)
      • Market Size and Forecast, By End User, 2018–2026 (US$ Mn)
      • Market Size and Forecast, By Country, 2018–2026 (US$ Mn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2018–2026 (US$ Mn)
      • Market Size and Forecast, By Modality, 2018–2026 (US$ Mn)
      • Market Size and Forecast, By Application, 2018–2026 (US$ Mn)
      • Market Size and Forecast, By Channel Type, 2018–2026 (US$ Mn)
      • Market Size and Forecast, By End User, 2018–2026 (US$ Mn)
      • Market Size and Forecast, By Country, 2018–2026 (US$ Mn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast, By Product Type, 2018–2026 (US$ Mn)
      • Market Size and Forecast, By Modality, 2018–2026 (US$ Mn)
      • Market Size and Forecast, By Application, 2018–2026 (US$ Mn)
      • Market Size and Forecast, By Channel Type, 2018–2026 (US$ Mn)
      • Market Size and Forecast, By End User, 2018–2026 (US$ Mn)
      • Market Size and Forecast, By Country, 2018–2026 (US$ Mn)
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East
      • Market Size and Forecast, By Product Type, 2018–2026 (US$ Mn)
      • Market Size and Forecast, By Modality, 2018–2026 (US$ Mn)
      • Market Size and Forecast, By Application, 2018–2026 (US$ Mn)
      • Market Size and Forecast, By Channel Type, 2018–2026 (US$ Mn)
      • Market Size and Forecast, By End User, 2018–2026 (US$ Mn)
      • Market Size and Forecast, By Country, 2018–2026 (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Product Type, 2018–2026 (US$ Mn)
      • Market Size and Forecast, By Modality, 2018–2026 (US$ Mn)
      • Market Size and Forecast, By Application, 2018–2026 (US$ Mn)
      • Market Size and Forecast, By Channel Type, 2018–2026 (US$ Mn)
      • Market Size and Forecast, By End User, 2018–2026 (US$ Mn)
      • Market Size and Forecast, By Country, 2018–2026 (US$ Mn)
        • Central Africa
        • South Africa
        • North Africa
  10. Competitive Landscape
    • Company Profiles
      • ICU Medical, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Smiths Group plc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Baxter International Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Fresenius Se & Co. KGaA
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Johnson & Johnson
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Medtronic plc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Becton, Dickinson and Company
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Terumo Corporation
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • B. Braun Melsungen AG
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Moog Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
  11. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 24 market data tables and 33 figures on "Programmable Infusion Pumps and Catheters Market- Global forecast to 2026”.

N/A
- Frequently Asked Questions -

What are the growth estimates for programmable infusion pumps and catheters market till 2026?

The global programmable infusion pumps and catheters market is estimated to surpass US$ 13.8 Billion by 2026.

Which are the prominent programmable infusion pumps and catheters market players across the globe?

Major players operating in the global programmable infusion pumps and catheters market include ICU Medical, Inc., Smiths Group plc., Baxter International Inc., Fresenius Se & Co. KGaA, Johnson & Johnson, Medtronic plc., Becton, Dickinson and Company, Terumo Corporation, B. Braun Melsungen AG, and Moog Inc.

What are the key factors hampering growth of the programmable infusion pumps and catheters market?

High costs of programmable infusion pumps and catheters is a major concern (in regions with underdeveloped reimbursement facilities) in the healthcare system. This is one of the major factors that is expected to hamper growth of the market over the forecast period.

What are the key factors driving growth of the programmable infusion pumps and catheters market?

Increasing launches of novel infusion pumps is one of the major factors that is expected to propel growth of the market over the forecast period.

What is the compound annual growth rate (CAGR) of the programmable infusion pumps and catheters market for next 8 years?

The global programmable infusion pumps and catheters market is estimated to exhibit a CAGR of 5.8% over the forecast period.

Which region is dominating theprogrammable infusion pumps and catheters market growth?

Among regions, North America is expected hold dominant position in the global programmable infusion pumps and catheters market over the forecast period.
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.